Effect of oral Atrovastatin on inflammatory factors in patients with traumatic brain injury

Phase 2

Recruiting

• Conditions: Traumatic Brain Injury.; Traumatic cerebral edema; S06.1

• Registration Number: IRCT20191016045127N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age between 18 to 50 years old
Patents with traumatic brain injury

Exclusion Criteria

patient’s lack of consent
Having allergy to Atrovastatin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eukocytosis. Timepoint: Days 1, 7, 10 and 15 after treatment. Method of measurement: Blood samples will be taken from patients and the values of White Blood Cells will be recorded in the checklist.;Leukocytopenia. Timepoint: Days 1, 7, 10 and 15 after treatment. Method of measurement: Blood samples will be taken from patients and the values of White Blood Cells will be recorded in the checklist.;Duration of Mechanical Ventilation. Timepoint: During Intervention. Method of measurement: Day.;Hospitalization. Timepoint: During Intervention. Method of measurement: Day.;Inflammatory Factors. Timepoint: 15 days after treatment. Method of measurement: Blood samples are taken from patients and the amount of inflammatory factors determined in the laboratory and will be recorded in the checklist.